HEADER HYDROLASE/HYDROLASE INHIBITOR 10-JUL-14 4QUH TITLE CASPASE-3 T140G COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32, PROTEIN COMPND 5 YAMA, SREBP CLEAVAGE ACTIVITY 1, SCA-1, CASPASE-3 SUBUNIT P17, COMPND 6 CASPASE-3 SUBUNIT P12; COMPND 7 EC: 3.4.22.56; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: SHORT PEPTDE; COMPND 12 CHAIN: D; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR; COMPND 16 CHAIN: I, J; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 MOL_ID: 3; SOURCE 11 SYNTHETIC: YES KEYWDS ALLOSTERIC NETWORK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.CADE,P.D.SWARTZ,S.H.MACKENZIE,A.C.CLARK REVDAT 3 22-NOV-17 4QUH 1 REMARK REVDAT 2 24-DEC-14 4QUH 1 JRNL REVDAT 1 05-NOV-14 4QUH 0 JRNL AUTH C.CADE,P.SWARTZ,S.H.MACKENZIE,A.C.CLARK JRNL TITL MODIFYING CASPASE-3 ACTIVITY BY ALTERING ALLOSTERIC JRNL TITL 2 NETWORKS. JRNL REF BIOCHEMISTRY V. 53 7582 2014 JRNL REFN ISSN 0006-2960 JRNL PMID 25343534 JRNL DOI 10.1021/BI500874K REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 56387 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.540 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.4638 - 4.2367 0.99 3982 143 0.1446 0.1743 REMARK 3 2 4.2367 - 3.3636 1.00 3925 147 0.1251 0.1590 REMARK 3 3 3.3636 - 2.9386 1.00 3925 143 0.1571 0.1710 REMARK 3 4 2.9386 - 2.6700 1.00 3902 137 0.1674 0.2267 REMARK 3 5 2.6700 - 2.4787 1.00 3925 142 0.1646 0.1696 REMARK 3 6 2.4787 - 2.3326 1.00 3892 147 0.1556 0.1942 REMARK 3 7 2.3326 - 2.2158 1.00 3907 145 0.1537 0.1901 REMARK 3 8 2.2158 - 2.1193 1.00 3939 140 0.1548 0.1843 REMARK 3 9 2.1193 - 2.0377 1.00 3890 146 0.1564 0.1924 REMARK 3 10 2.0377 - 1.9674 1.00 3853 143 0.1575 0.2056 REMARK 3 11 1.9674 - 1.9059 1.00 3915 148 0.1609 0.1866 REMARK 3 12 1.9059 - 1.8514 0.99 3900 137 0.1711 0.2316 REMARK 3 13 1.8514 - 1.8027 0.98 3831 146 0.1824 0.2147 REMARK 3 14 1.8027 - 1.7587 0.93 3604 133 0.1915 0.2250 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4101 REMARK 3 ANGLE : 1.067 5530 REMARK 3 CHIRALITY : 0.049 596 REMARK 3 PLANARITY : 0.004 709 REMARK 3 DIHEDRAL : 13.395 1560 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QUH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000086528. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56387 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.759 REMARK 200 RESOLUTION RANGE LOW (A) : 36.456 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEINS WERE DIALYZED IN A BUFFER OF REMARK 280 10 MM TRIS-HCL, PH 8.5, 1 MM DTT AND CONCENTRATED TO 10 MG/ML. REMARK 280 INHIBITOR, AC-DEVD-CMK RECONSTITUTED IN DMSO, WAS THEN ADDED AT REMARK 280 A 5:1 INHIBITOR:PEPTIDE RATIO (W/W). THE PROTEIN WAS DILUTED TO REMARK 280 A CONCENTRATION OF 8 MG/ML BY ADDING 10 MM TRIS-HCL, PH 8.5, REMARK 280 CONCENTRATED DTT, AND CONCENTRATED NAN3 SO THAT THE FINAL BUFFER REMARK 280 CONSISTED OF 10 MM TRIS-HCL, PH 8.5, 10 MM DTT, AND 3 MM NAN3. REMARK 280 CRYSTALS WERE OBTAINED AT 291 BY THE HANGING DROP VAPOR REMARK 280 DIFFUSION METHOD USING 4 L DROPS THAT CONTAINED EQUAL VOLUMES OF REMARK 280 PROTEIN AND RESERVOIR SOLUTIONS OVER A 0.5 ML RESERVOIR. THE REMARK 280 RESERVOIR SOLUTIONS FOR OPTIMAL CRYSTAL GROWTH CONSISTED OF 100 REMARK 280 MM SODIUM CITRATE, PH 5.0, 3 MM NAN3, 10 MM DTT, AND 10% 16% PEG REMARK 280 6000 (W/V). CRYSTALS APPEARED WITHIN 3.5 TO 6 WEEKS FOR ALL REMARK 280 MUTANTS, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.98650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.42250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.98650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.42250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 505 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: I, J REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 VAL A 8 REMARK 465 ASP A 9 REMARK 465 SER A 10 REMARK 465 LYS A 11 REMARK 465 SER A 12 REMARK 465 ILE A 13 REMARK 465 LYS A 14 REMARK 465 ASN A 15 REMARK 465 LEU A 16 REMARK 465 GLU A 17 REMARK 465 PRO A 18 REMARK 465 LYS A 19 REMARK 465 ILE A 20 REMARK 465 ILE A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ASP A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 ASP A 175 REMARK 465 SER A 176 REMARK 465 GLY A 177 REMARK 465 VAL A 178 REMARK 465 ASP A 179 REMARK 465 ASP A 180 REMARK 465 ASP A 181 REMARK 465 MET A 182 REMARK 465 ALA A 183 REMARK 465 CYS A 184 REMARK 465 HIS A 277 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 ASN C 3 REMARK 465 THR C 4 REMARK 465 GLU C 5 REMARK 465 ASN C 6 REMARK 465 SER C 7 REMARK 465 VAL C 8 REMARK 465 ASP C 9 REMARK 465 SER C 10 REMARK 465 LYS C 11 REMARK 465 SER C 12 REMARK 465 ILE C 13 REMARK 465 LYS C 14 REMARK 465 ASN C 15 REMARK 465 LEU C 16 REMARK 465 GLU C 17 REMARK 465 PRO C 18 REMARK 465 LYS C 19 REMARK 465 ILE C 20 REMARK 465 ILE C 21 REMARK 465 HIS C 22 REMARK 465 GLY C 23 REMARK 465 SER C 24 REMARK 465 GLU C 25 REMARK 465 SER C 26 REMARK 465 MET C 27 REMARK 465 ASP C 28 REMARK 465 SER C 29 REMARK 465 GLY C 30 REMARK 465 ILE C 31 REMARK 465 SER C 32 REMARK 465 LEU C 33 REMARK 465 ASP C 175 REMARK 465 SER C 176 REMARK 465 GLY C 177 REMARK 465 VAL C 178 REMARK 465 ASP C 179 REMARK 465 ASP C 180 REMARK 465 ASP C 181 REMARK 465 MET C 182 REMARK 465 ALA C 183 REMARK 465 HIS C 277 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 34 CG OD1 OD2 REMARK 470 ASP C 34 CG OD1 OD2 REMARK 470 GLU C 173 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 466 O HOH C 564 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 61 130.78 53.53 REMARK 500 SER A 120 -177.85 -170.04 REMARK 500 ARG C 64 71.40 -100.49 REMARK 500 LYS C 82 30.36 72.18 REMARK 500 ASP D 179 93.16 78.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTT C 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF SHORT PEPTDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF ACE-ASP-GLU-VAL-ASP REMARK 800 -CHLOROMETHYLKETONE INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN J OF ACE-ASP-GLU-VAL-ASP REMARK 800 -CHLOROMETHYLKETONE INHIBITOR DBREF 4QUH A 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 4QUH C 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 4QUH D 177 181 PDB 4QUH 4QUH 177 181 DBREF 4QUH I 1 6 PDB 4QUH 4QUH 1 6 DBREF 4QUH J 1 6 PDB 4QUH 4QUH 1 6 SEQADV 4QUH GLY A 140 UNP P42574 THR 140 ENGINEERED MUTATION SEQADV 4QUH GLY C 140 UNP P42574 THR 140 ENGINEERED MUTATION SEQRES 1 A 277 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 A 277 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 A 277 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 A 277 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 A 277 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 A 277 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 A 277 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 A 277 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 A 277 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 A 277 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 A 277 ASN GLY PRO VAL ASP LEU LYS LYS ILE GLY ASN PHE PHE SEQRES 12 A 277 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 A 277 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 277 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 A 277 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 A 277 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 A 277 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 A 277 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 A 277 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 A 277 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 A 277 GLN ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU SEQRES 22 A 277 TYR PHE TYR HIS SEQRES 1 C 277 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 C 277 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 C 277 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 C 277 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 C 277 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 C 277 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 C 277 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 C 277 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 C 277 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 C 277 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 C 277 ASN GLY PRO VAL ASP LEU LYS LYS ILE GLY ASN PHE PHE SEQRES 12 C 277 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 C 277 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 C 277 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 C 277 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 C 277 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 C 277 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 C 277 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 C 277 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 C 277 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 C 277 GLN ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU SEQRES 22 C 277 TYR PHE TYR HIS SEQRES 1 D 5 GLY VAL ASP ASP ASP SEQRES 1 I 6 ACE ASP GLU VAL ASP 0QE SEQRES 1 J 6 ACE ASP GLU VAL ASP 0QE HET ACE I 1 3 HET 0QE I 6 1 HET ACE J 1 3 HET 0QE J 6 1 HET MRD A 301 8 HET AZI A 302 3 HET AZI A 303 3 HET MRD C 301 8 HET AZI C 302 3 HET AZI C 303 3 HET DTT C 304 8 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM AZI AZIDE ION HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETSYN 0QE CHLORO METHYL GROUP HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 4 ACE 2(C2 H4 O) FORMUL 4 0QE 2(C H3 CL) FORMUL 6 MRD 2(C6 H14 O2) FORMUL 7 AZI 4(N3 1-) FORMUL 12 DTT C4 H10 O2 S2 FORMUL 13 HOH *421(H2 O) HELIX 1 1 GLY A 66 LEU A 81 1 16 HELIX 2 2 THR A 92 LYS A 105 1 14 HELIX 3 3 LEU A 136 PHE A 142 1 7 HELIX 4 4 CYS A 148 THR A 152 5 5 HELIX 5 5 TRP A 214 ALA A 227 1 14 HELIX 6 6 GLU A 231 PHE A 247 1 17 HELIX 7 7 ASP A 253 HIS A 257 5 5 HELIX 8 8 HIS C 56 GLY C 60 5 5 HELIX 9 9 GLY C 66 LEU C 81 1 16 HELIX 10 10 THR C 92 LYS C 105 1 14 HELIX 11 11 LEU C 136 PHE C 142 1 7 HELIX 12 12 CYS C 148 THR C 152 5 5 HELIX 13 13 TRP C 214 ALA C 227 1 14 HELIX 14 14 GLU C 231 PHE C 247 1 17 HELIX 15 15 ASP C 253 HIS C 257 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 A12 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A12 PHE A 193 TYR A 197 1 O LEU A 194 N PHE A 158 SHEET 6 A12 CYS A 264 SER A 267 -1 O VAL A 266 N TYR A 195 SHEET 7 A12 CYS C 264 SER C 267 -1 O SER C 267 N ILE A 265 SHEET 8 A12 PHE C 193 TYR C 197 -1 N TYR C 195 O VAL C 266 SHEET 9 A12 LYS C 156 GLN C 161 1 N PHE C 158 O ALA C 196 SHEET 10 A12 ARG C 111 LEU C 119 1 N PHE C 114 O LEU C 157 SHEET 11 A12 GLU C 43 ASN C 51 1 N ILE C 48 O VAL C 117 SHEET 12 A12 GLU C 84 ASN C 89 1 O LYS C 88 N ASN C 51 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 C 2 ILE A 172 GLU A 173 0 SHEET 2 C 2 LYS C 186 ILE C 187 -1 O ILE C 187 N ILE A 172 SHEET 1 D 2 LYS A 186 ILE A 187 0 SHEET 2 D 2 ILE C 172 GLU C 173 -1 O ILE C 172 N ILE A 187 SHEET 1 E 3 GLY A 212 SER A 213 0 SHEET 2 E 3 TRP A 206 ASN A 208 -1 N ASN A 208 O GLY A 212 SHEET 3 E 3 GLU J 3 VAL J 4 -1 O GLU J 3 N ARG A 207 SHEET 1 F 3 GLY C 122 GLU C 123 0 SHEET 2 F 3 ILE C 126 GLY C 129 -1 O ILE C 126 N GLU C 123 SHEET 3 F 3 GLY C 132 ASP C 135 -1 O GLY C 132 N GLY C 129 SHEET 1 G 3 GLY C 212 SER C 213 0 SHEET 2 G 3 TRP C 206 ASN C 208 -1 N ASN C 208 O GLY C 212 SHEET 3 G 3 GLU I 3 VAL I 4 -1 O GLU I 3 N ARG C 207 LINK C ACE I 1 N ASP I 2 1555 1555 1.43 LINK C ASP I 5 C1 0QE I 6 1555 1555 1.52 LINK C ACE J 1 N ASP J 2 1555 1555 1.44 LINK C ASP J 5 C1 0QE J 6 1555 1555 1.52 CISPEP 1 GLY D 177 VAL D 178 0 -0.13 SITE 1 AC1 8 LYS A 137 TYR A 195 TYR A 197 MET A 268 SITE 2 AC1 8 HOH A 460 HOH A 462 HOH A 538 PRO C 201 SITE 1 AC2 5 LYS A 53 GLY A 66 THR A 67 ASP A 68 SITE 2 AC2 5 VAL A 69 SITE 1 AC3 5 ASN A 73 CYS A 220 ALA A 221 LYS A 224 SITE 2 AC3 5 HOH A 439 SITE 1 AC4 7 HOH A 549 LEU C 136 LYS C 137 TYR C 195 SITE 2 AC4 7 TYR C 197 HOH C 496 HOH C 563 SITE 1 AC5 4 GLY C 66 THR C 67 ASP C 68 VAL C 69 SITE 1 AC6 3 ASN C 80 LEU C 81 PHE C 275 SITE 1 AC7 5 HOH A 577 ARG C 75 ARG C 86 ASN C 87 SITE 2 AC7 5 ASN C 89 SITE 1 AC8 10 ARG A 75 ARG A 86 ASN A 87 LYS A 88 SITE 2 AC8 10 ASN A 89 HOH A 599 HOH D 201 HOH D 202 SITE 3 AC8 10 HOH D 203 HOH D 204 SITE 1 AC9 25 SER C 58 ARG C 64 HIS C 121 GLY C 122 SITE 2 AC9 25 GLN C 161 CYS C 163 TYR C 204 SER C 205 SITE 3 AC9 25 TRP C 206 ARG C 207 ASN C 208 SER C 209 SITE 4 AC9 25 TRP C 214 SER C 249 PHE C 250 HOH C 432 SITE 5 AC9 25 HOH C 493 HOH C 580 HOH I 101 HOH I 102 SITE 6 AC9 25 HOH I 103 HOH I 104 HOH I 105 HOH I 106 SITE 7 AC9 25 HOH I 108 SITE 1 BC1 21 ARG A 64 HIS A 121 GLY A 122 GLN A 161 SITE 2 BC1 21 CYS A 163 TYR A 204 SER A 205 TRP A 206 SITE 3 BC1 21 ARG A 207 ASN A 208 SER A 209 TRP A 214 SITE 4 BC1 21 SER A 249 PHE A 250 HOH A 416 HOH A 481 SITE 5 BC1 21 HOH J 101 HOH J 102 HOH J 103 HOH J 104 SITE 6 BC1 21 HOH J 105 CRYST1 113.973 96.845 68.866 90.00 129.95 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008774 0.000000 0.007349 0.00000 SCALE2 0.000000 0.010326 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018942 0.00000